This inventor holds 1 USPTO granted patent. Top assignee: The Dupont Merck Pharmaceutical Company. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Bobby E. Corry: Innovator in Radiopharmaceuticals
Introduction
Bobby E. Corry is a notable inventor based in Merrimack, NH (US). He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative patent that enhances the preparation of these critical formulations.
Latest Patents
Bobby E. Corry holds a patent for an "Apparatus and method for the preparation of a radiopharmaceutical." This invention utilizes a radiation-shielding container designed to receive a vial containing non-radioactive components necessary for forming a radiopharmaceutical formulation. The method involves heating and cooling a mixture of non-radioactive components and a radioactive liquid using a thermoelectric element. The container features a hollow outer shielding member made from radiation shielding material and a vial holder constructed from a highly heat conductive material. This design allows for efficient thermal management while ensuring safety during the production of radiopharmaceuticals.
Career Highlights
Bobby E. Corry is associated with The Dupont Merck Pharmaceutical Company, where he has applied his expertise in the development of radiopharmaceuticals. His work has contributed to advancements in medical imaging and treatment, showcasing his commitment to improving healthcare through innovation.
Collaborations
Throughout his career, Bobby has collaborated with esteemed colleagues, including James F. Castner and Thomas David Harris. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.
Conclusion
Bobby E. Corry's contributions to the field of radiopharmaceuticals exemplify the impact of innovation in healthcare. His patented methods and apparatus are vital for the safe and effective preparation of radiopharmaceutical formulations.